[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition].

N V Kuzmenko, V A Tsyrlin, M G Pliss
{"title":"[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition].","authors":"N V Kuzmenko, V A Tsyrlin, M G Pliss","doi":"10.14341/probl13396","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Melatonin is known to modulate circadian and seasonal rhythms in metabolism, reproduction, and behavior. However, the effect of exogenous melatonin supplementation on the functioning of the thyroid and adrenal glands in species without a clear seasonality in reproduction is still unclear.</p><p><strong>Aim: </strong>Using a meta-analysis of publications, to investigate the effect of melatonin monotherapy on the concentrations of pituitary thyroid-stimulating hormone, thyroid hormones (TG), pituitary adrenocorticotropic hormone and corticosterone (CS) in rats kept under standard laboratory conditions.</p><p><strong>Materials and methods: </strong>In our work, using the Review Manager 5.3 program, we conducted a meta-analysis of publications examining the effect of melatonin monotherapy on the functioning of the thyroid gland (22 papers) and adrenal glands (20 papers) in rats kept under standard conditions.</p><p><strong>Results: </strong>According to the results of our meta-analysis, the effects of melatonin on the levels of TG and CS depend on the dose and duration of therapy. A decrease in TG and CS was associated with therapy lasting no more than 4-5 weeks and with high doses of melatonin. An increase in CS and a trend toward increased TG levels were observed with longer therapy. However, a few studies have observed a decrease in TG with very long-term melatonin therapy (≥32 weeks). Among all TGs, total thyroxine (T4) showed maximum sensitivity to exogenous melatonin, which indicates the influence of melatonin on the secretory function of the thyroid gland. In addition, melatonin increased the relative weight of the adrenal glands. There was no convincing evidence that the effects of melatonin were influenced by the route and timing of administration, or the timing of blood sampling.</p><p><strong>Conclusion: </strong>As a result, exogenous melatonin can modulate TG and CS levels, even in species without a clear seasonality in reproductive function.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"70 5","pages":"91-105"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy endokrinologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/probl13396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Melatonin is known to modulate circadian and seasonal rhythms in metabolism, reproduction, and behavior. However, the effect of exogenous melatonin supplementation on the functioning of the thyroid and adrenal glands in species without a clear seasonality in reproduction is still unclear.

Aim: Using a meta-analysis of publications, to investigate the effect of melatonin monotherapy on the concentrations of pituitary thyroid-stimulating hormone, thyroid hormones (TG), pituitary adrenocorticotropic hormone and corticosterone (CS) in rats kept under standard laboratory conditions.

Materials and methods: In our work, using the Review Manager 5.3 program, we conducted a meta-analysis of publications examining the effect of melatonin monotherapy on the functioning of the thyroid gland (22 papers) and adrenal glands (20 papers) in rats kept under standard conditions.

Results: According to the results of our meta-analysis, the effects of melatonin on the levels of TG and CS depend on the dose and duration of therapy. A decrease in TG and CS was associated with therapy lasting no more than 4-5 weeks and with high doses of melatonin. An increase in CS and a trend toward increased TG levels were observed with longer therapy. However, a few studies have observed a decrease in TG with very long-term melatonin therapy (≥32 weeks). Among all TGs, total thyroxine (T4) showed maximum sensitivity to exogenous melatonin, which indicates the influence of melatonin on the secretory function of the thyroid gland. In addition, melatonin increased the relative weight of the adrenal glands. There was no convincing evidence that the effects of melatonin were influenced by the route and timing of administration, or the timing of blood sampling.

Conclusion: As a result, exogenous melatonin can modulate TG and CS levels, even in species without a clear seasonality in reproductive function.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[关于褪黑素单一疗法对标准条件下饲养的大鼠甲状腺激素和糖皮质激素水平影响的实验研究的元分析]。
背景:众所周知,褪黑激素可调节新陈代谢、繁殖和行为的昼夜节律和季节性节律。目的:通过对出版物进行荟萃分析,研究褪黑激素单一疗法对标准实验室条件下饲养的大鼠垂体促甲状腺激素、甲状腺激素(TG)、垂体促肾上腺皮质激素和皮质酮(CS)浓度的影响:我们使用Review Manager 5.3程序对研究褪黑素单一疗法对标准条件下饲养大鼠甲状腺(22篇)和肾上腺(20篇)功能影响的文献进行了荟萃分析:根据我们的荟萃分析结果,褪黑素对TG和CS水平的影响取决于剂量和疗程。治疗时间不超过 4-5 周且褪黑素剂量较大时,TG 和 CS 会下降。治疗时间越长,CS 水平越高,TG 水平也呈上升趋势。不过,也有少数研究观察到,褪黑素治疗时间过长(≥32 周)会导致 TG 下降。在所有总胆固醇中,总甲状腺素(T4)对外源性褪黑激素的敏感性最高,这表明褪黑激素对甲状腺的分泌功能有影响。此外,褪黑激素还增加了肾上腺的相对重量。没有令人信服的证据表明褪黑激素的作用受给药途径、给药时间或采血时间的影响:因此,即使在生殖功能没有明显季节性的物种中,外源性褪黑激素也能调节TG和CS水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Meta-analysis of experimental studies of the effect of melatonin monotherapy on the levels of thyroid hormones and glucocorticoids in rats kept under standard condition]. [Metastatic pituitary lesion]. [The role of leptin in endometrium disorders: literature review]. [Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo]. [Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1